These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7489366)

  • 1. Identification of a novel dual angiotensin II/vasopressin receptor on the basis of molecular recognition theory.
    Ruiz-Opazo N; Akimoto K; Herrera VL
    Nat Med; 1995 Oct; 1(10):1074-81. PubMed ID: 7489366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of a dual endothelin-1/Angiotensin II receptor.
    Ruiz-Opazo N; Hirayama K; Akimoto K; Herrera VL
    Mol Med; 1998 Feb; 4(2):96-108. PubMed ID: 9508787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel V1-type AVP receptor based on the molecular recognition theory.
    Herrera VL; Ruiz-Opazo N
    Mol Med; 2001 Jul; 7(7):499-506. PubMed ID: 11683375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel dual angiotensin II/vasopressin receptor.
    Ruiz-Opazo N
    Nephrologie; 1998; 19(7):417-20. PubMed ID: 9857377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal immunocytochemical distribution and pharmacological properties of the dual angiotensin II/AVP receptor.
    Gonzalez CB; Herrera VL; Ruiz-Opazo N
    Hypertension; 1997 Apr; 29(4):957-61. PubMed ID: 9095083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of the human arginine vasopressin V2 receptor after site-directed mutagenesis of its putative palmitoylation site.
    Schülein R; Liebenhoff U; Müller H; Birnbaumer M; Rosenthal W
    Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):611-6. PubMed ID: 8573100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dual AngII/AVP receptor gene N119S/C163R variant exhibits sodium-induced dysfunction and cosegregates with salt-sensitive hypertension in the Dahl salt-sensitive hypertensive rat model.
    Ruiz-Opazo N; Lopez LV; Herrera VL
    Mol Med; 2002 Jan; 8(1):24-32. PubMed ID: 11984003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding and signal transduction of the cloned vascular angiotensin II (AT1a) receptor cDNA stably expressed in Chinese hamster ovary cells.
    Webb ML; Monshizadegan H; Dickinson KE; Serafino R; Moreland S; Michel I; Seiler SM; Murphy TJ
    Regul Pept; 1993 Mar; 44(2):131-9. PubMed ID: 8469768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus.
    Lolait SJ; O'Carroll AM; McBride OW; Konig M; Morel A; Brownstein MJ
    Nature; 1992 May; 357(6376):336-9. PubMed ID: 1534150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs/adenylyl cyclase system.
    Birnbaumer M; Gilbert S; Rosenthal W
    Mol Endocrinol; 1994 Jul; 8(7):886-94. PubMed ID: 7984150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlapping genes in Nalp6/PYPAF5 locus encode two V2-type vasopressin isoreceptors: angiotensin-vasopressin receptor (AVR) and non-AVR.
    Herrera VL; Bagamasbad P; Didishvili T; Decano JL; Ruiz-Opazo N
    Physiol Genomics; 2008 Jun; 34(1):65-77. PubMed ID: 18413781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity capture of [Arg8]vasopressin-receptor complex using immobilized antisense peptide.
    Lu FX; Aiyar N; Chaiken I
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3642-6. PubMed ID: 2023913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the genes encoding the vasopressin-activated calcium-mobilizing receptor and the dual angiotensin II/vasopressin receptor in the rat central nervous system.
    Hurbin A; Orcel H; Ferraz C; Moos FC; Rabié A
    J Neuroendocrinol; 2000 Jul; 12(7):677-84. PubMed ID: 10849213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of the structure and molecular functions of angiotensin II and vasopressin receptors].
    Clauser E
    C R Seances Soc Biol Fil; 1995; 189(2):179-90. PubMed ID: 8590217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin antisense peptide interactions with the V1 receptor.
    Kelly JM; Trinder D; Phillips PA; Casley DJ; Kemp B; Mooser V; Johnston CI
    Peptides; 1990; 11(4):857-62. PubMed ID: 2146598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrapituitary expression of the rat V1b vasopressin receptor gene.
    Lolait SJ; O'Carroll AM; Mahan LC; Felder CC; Button DC; Young WS; Mezey E; Brownstein MJ
    Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6783-7. PubMed ID: 7624319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrogenic diabetes insipidus. A V2 vasopressin receptor unable to stimulate adenylyl cyclase.
    Rosenthal W; Antaramian A; Gilbert S; Birnbaumer M
    J Biol Chem; 1993 Jun; 268(18):13030-3. PubMed ID: 8514744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An antibody directed against a peptide encoded by RNA complementary to mRNA for vasopressin recognizes putative vasopressin receptors.
    Swords BH; Carr DJ; Blalock JE; Berecek KH
    Neuroendocrinology; 1990 Apr; 51(4):487-92. PubMed ID: 2140594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocytochemistry of a vasopressin (AVP) receptor with anti-idiotype antibody: inhibition of staining with a peptide (PVA) encoded by an RNA that is complementary to AVP mRNA.
    Knigge KM; Piekut DT; Berlove D
    Neurosci Lett; 1988 Apr; 86(3):269-71. PubMed ID: 3380318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural requirements for V2 vasopressin receptor proteolytic cleavage.
    Kojro E; Postina R; Gilbert S; Bender F; Krause G; Fahrenholz F
    Eur J Biochem; 1999 Dec; 266(2):538-48. PubMed ID: 10561596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.